Northville, MI, United States of America

Xiao Hu

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Innovations by Inventor Xiao Hu

Introduction

Xiao Hu is a prominent inventor based in Northville, MI (US). She has made significant contributions to the field of medical therapy, particularly in the area of adoptive cellular therapies. With a total of 4 patents, her work is paving the way for advancements in cancer treatment and immune response enhancement.

Latest Patents

Xiao Hu's latest patents include groundbreaking inventions that utilize an agonist of the retinoic acid receptor-related orphan receptor gamma (RORγ). One of her notable inventions is titled "Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods." This invention focuses on enhancing therapeutic effects of lymphocyte and dendritic cells in patients through the administration of RORγ agonists. Another significant patent is "Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease." This invention provides methods for promoting ROR activity and treating cancer using specific compounds.

Career Highlights

Xiao Hu is currently associated with Lycera Corporation, where she continues to innovate and develop new therapeutic methods. Her work is instrumental in advancing the understanding and application of cellular therapies in medicine.

Collaborations

Xiao Hu collaborates with esteemed colleagues such as Thomas Daniel Aicher and Peter Laurence Toogood. Their combined expertise contributes to the success of their projects and the advancement of medical therapies.

Conclusion

Xiao Hu's contributions to the field of medical therapy through her innovative patents are noteworthy. Her work not only enhances therapeutic methods but also holds promise for future advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…